Production (Stage)
Akebia Therapeutics, Inc.
AKBA
$2.86
$0.031.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 118.57% | 52.47% | -13.87% | -5.87% | -2.25% |
| Total Receivables | 79.06% | 6.83% | 8.08% | 11.81% | -32.25% |
| Inventory | 21.48% | -20.74% | -14.15% | -6.50% | 62.72% |
| Prepaid Expenses | -69.69% | -44.25% | -37.87% | -17.02% | -3.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.14% | 17.87% | -15.25% | 52.28% | -16.35% |
| Total Current Assets | 79.02% | 13.69% | -10.68% | -0.75% | -4.41% |
|
|
|||||
| Total Current Assets | 79.02% | 13.69% | -10.68% | -0.75% | -4.41% |
| Net Property, Plant & Equipment | -13.44% | -11.96% | -10.73% | -9.61% | -8.61% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -100.00% | -50.00% | -33.33% | -25.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.58% | 37.75% | 52.62% | 50.76% | -5.07% |
| Total Assets | 40.57% | 6.53% | -5.93% | -2.34% | -6.71% |
|
|
|||||
| Total Accounts Payable | -16.61% | 12.49% | 33.51% | -14.94% | -18.81% |
| Total Accrued Expenses | 19.57% | 18.10% | 3.44% | 1.75% | -37.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.53% | 29.09% | 4.62% | 1.80% | -70.61% |
| Total Finance Division Other Current Liabilities | 10.92% | 37.72% | -73.68% | 202.14% | 13.77% |
| Total Other Current Liabilities | 10.92% | 37.72% | -73.68% | 202.14% | 13.77% |
| Total Current Liabilities | 12.75% | 23.14% | -38.76% | 61.38% | -33.43% |
|
|
|||||
| Total Current Liabilities | 12.75% | 23.14% | -38.76% | 61.38% | -33.43% |
| Long-Term Debt | 2.54% | 93.38% | -0.43% | 8.95% | -24.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -40.15% | -28.15% | -21.62% | -17.51% | -14.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.27% | -89.68% | 95.38% | -48.17% | 82.00% |
| Total Liabilities | 5.84% | 4.78% | 1.42% | 0.48% | -7.18% |
|
|
|||||
| Common Stock & APIC | 4.15% | 1.50% | 0.21% | 0.13% | 1.35% |
| Retained Earnings | 0.36% | -1.38% | -1.23% | -0.53% | -1.12% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 149.98% | 2.41% | -49.32% | -23.83% | 10.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 149.98% | 2.41% | -49.32% | -23.83% | 10.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 149.98% | 2.41% | -49.32% | -23.83% | 10.87% |
|
|
|||||